Azeez Farooki

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Bone Mineral Density: Clinical Relevance and Quantitative Assessment”.

Bone Mineral Density: Clinical Relevance and Quantitative Assessment

Journal of Nuclear Medicine(2020)10.2967/jnumed.120.256180

N/A

0DataRank · unranked

115 citations

Tariq Chukir, Pinar J. Smith, Justin T. Jacob, John P. Bilezikian, Azeez Farooki +1 more

Vertebral fractures after denosumab discontinuation in breast cancer survivors---a single institution experience

(2020)10.22541/au.159559760.00545148

N/A

0DataRank · unranked

2 citations

Kaylee Ho, Monica Fornier, Azeez Farooki, Michele Yeung

Association of radical cystectomy and increased risk of skeletal-related events in bone-metastatic urothelial carcinoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.477

N/A

0DataRank · unranked

0 citations

Imaani Easthausen, Soleen Ghafoor, Paul J. Christos, Timothy F. Donahue, Jonathan E. Rosenberg +2 more

Real-world use of bone modifying agents in metastatic, castration-resistant prostate cancer

Prostate Cancer and Prostatic Diseases(2022)10.1038/s41391-022-00573-y

N/A

0DataRank · unranked

13 citations

Akriti Mishra Meza, Katherine S. Panageas, Allison Lipitz‐Snyderman, Azeez Farooki, Michael J. Morris +1 more

Use of bone modifying agents for metastatic castrate-resistant prostate cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.055

N/A

0DataRank · unranked

0 citations

Akriti Mishra Meza, Azeez Farooki, Katherine S. Panageas, Peter B. Bach, Allison Lipitz‐Snyderman +2 more

Refractory hypercalcemia of malignancy: a problem with many potential roots

Frontiers in Endocrinology(2023)10.3389/fendo.2023.1088984

N/A

0DataRank · unranked

5 citations

Azeez Farooki

Physician knowledge, practice patterns, and barriers encountered regarding guideline‐concordant use of bone modifying agents for prostate cancer

The Prostate(2023)10.1002/pros.24636

N/A

0DataRank · unranked

2 citations

Sonia Persaud, Paul Palyca, Andrew Salner, Azeez Farooki, Jamie S. Ostroff +3 more

Cost to Medicare from bone modifying agent overuse in castration-sensitive prostate cancer.

JCO Oncology Practice(2023)10.1200/op.2023.19.11_suppl.12

N/A

0DataRank · unranked

1 citations

Nirjhar Chakraborty, David Nemirovsky, Akriti Mishra Meza, Sonia Persaud, Azeez Farooki +2 more

Barriers to guideline-concordant use of bone modifying agents for prostate cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.68

N/A

0DataRank · unranked

0 citations

Sonia Persaud, Susan Chimonas, Andrew Salner, Paul Palyca, Azeez Farooki +3 more

Teriparatide as an adjuvant therapy in the management of advanced-stage medication-related osteonecrosis of the jaw

Oral Surgery Oral Medicine Oral Pathology and Oral Radiology(2025)10.1016/j.oooo.2025.04.001

N/A

0DataRank · unranked

1 citations

Kevin C. Chung, Joseph M. Huryn, Cherry L. Estilo, Azeez Farooki, SaeHee K. Yom +1 more